We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image Credit: iStock

Liquid Biopsy Captures Gene Activity Patterns in Small-Cell Lung Cancer

A new blood-based cfChIP-seq test tracks small-cell lung cancer burden, monitors treatment response, and profiles subtypes. More...
12 Nov 2026
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

A new urine biomarker score improves five-year cancer risk prediction, including for cancers without established screening programs. More...
12 Nov 2026
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

A new blood RNA test detects fallopian tube precancer and early ovarian cancer with 92% sensitivity and 98% specificity. More...
11 Nov 2026
Image: FDA approval enables the OncoMate MSI Dx Analysis System to identify patients who may benefit from Merck’s KEYTRUDA anti-PD-1 therapy. (Photo courtesy of Promega)

Microsatellite Instability Test Gains FDA Approval for Immunotherapy Selection

A new PCR-based test gains FDA approval to identify MSI-high solid tumors and help guide KEYTRUDA treatment. More...
11 Nov 2026
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

C2N Diagnostics and LSI Medience have partnered to seek approval and commercialize the PrecivityAD2 test in Japan. More...
11 Nov 2026
Graphical overview of the study design and colorectal cancer risk stratification using blood-detected mosaic chromosomal alterations (mCAs). The schematic summarizes mCA detection and genomic features, factors associated with mCA carriage, and the integration of mCAs with germline polygenic risk and lifestyle factors for colorectal cancer risk assessment. (Image Credit: ©Science Bulletin)

Blood-Detected Chromosomal Changes May Refine Colorectal Cancer Risk Assessment

New data show blood-detected mosaic chromosomal changes refine colorectal cancer risk stratification beyond genetics and lifestyle. More...
11 Nov 2026
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

A new multiplex PCR test gains CE-IVDR marking, enabling rapid single-sample detection of 13 respiratory pathogens. More...
11 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Copyright © 2000-2026 Globetech Media. All rights reserved.